Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Bruno Massidda

Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated With FOLFOX-4 or XELOX Adjuvant Chemotherapy

Scientific Reports

Multidisciplinary

2019

English

Cisplatin and Gemcitabine With Either Vinorelbine or Paclitaxel in the Treatment of Carcinomas of Unknown Primary Site

English

Related publications

Compliance of Patients With Locally Advanced Colorectal Cancer to Chemotherapy Using FOLFOX Compared to XELOX Regimen

The New Ropanasuri Journal of Surgery

2016

English

Efficacy and Safety of XELOX and FOLFOX6 Adjuvant Chemotherapy Following Radical Total Gastrectomy

English

Clinical Impact of Delaying Initiation of Adjuvant Chemotherapy in Patients With Breast Cancer

Journal of Clinical Oncology

English

Effects of Modified FOLFOX-6 Chemotherapy on Cellular Immune Function in Patients With Gastric Cancer

English

GOLPH3 Predicts Survival of Colorectal Cancer Patients Treated With 5-Fluorouracil-Based Adjuvant Chemotherapy

Journal of Translational Medicine

English

Use of a Multigene Prognostic Assay for Selection of Adjuvant Chemotherapy in Patients With Stage II Colon Cancer: Impact on Quality-Adjusted Life Expectancy and Costs.

Journal of Clinical Oncology

English

Adjuvant Chemotherapy Does Not Provide Survival Benefits to Elderly Patients With Stage II Colon Cancer

Scientific Reports

Multidisciplinary

2019

English

Impact of Diabetes Mellitus on Complications and Outcomes of Adjuvant Chemotherapy in Older Patients With Breast Cancer

Journal of Clinical Oncology

English

Intraperitoneal Chemotherapy in Patients Pretreated for Ovarian Cancer Matched With Patients Treated With Parenteral Chemotherapy

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Bruno Massidda

Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated With FOLFOX-4 or XELOX Adjuvant Chemotherapy

Cisplatin and Gemcitabine With Either Vinorelbine or Paclitaxel in the Treatment of Carcinomas of Unknown Primary Site

Related publications

Compliance of Patients With Locally Advanced Colorectal Cancer to Chemotherapy Using FOLFOX Compared to XELOX Regimen

Efficacy and Safety of XELOX and FOLFOX6 Adjuvant Chemotherapy Following Radical Total Gastrectomy

Clinical Impact of Delaying Initiation of Adjuvant Chemotherapy in Patients With Breast Cancer

Effects of Modified FOLFOX-6 Chemotherapy on Cellular Immune Function in Patients With Gastric Cancer

GOLPH3 Predicts Survival of Colorectal Cancer Patients Treated With 5-Fluorouracil-Based Adjuvant Chemotherapy

Use of a Multigene Prognostic Assay for Selection of Adjuvant Chemotherapy in Patients With Stage II Colon Cancer: Impact on Quality-Adjusted Life Expectancy and Costs.

Adjuvant Chemotherapy Does Not Provide Survival Benefits to Elderly Patients With Stage II Colon Cancer

Impact of Diabetes Mellitus on Complications and Outcomes of Adjuvant Chemotherapy in Older Patients With Breast Cancer

Intraperitoneal Chemotherapy in Patients Pretreated for Ovarian Cancer Matched With Patients Treated With Parenteral Chemotherapy